We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Koninklijke Philips NV | EU:PHIA | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.06 | -0.24% | 24.78 | 24.76 | 24.78 | 25.10 | 24.67 | 25.03 | 1,261,424 | 15:16:02 |
From May 2019 to May 2024
By Adriano Marchese
Koninklijke Philips NV said Tuesday that it has received clearance from the U.S. Food and Drug Administration for its wearable biosensor for confirmed and suspected coronavirus patients.
The Dutch technology company said the solution has already received CE mark, and is currently in use with the first install at the OLVG Hospital--a clinical, referral and training hospital in the Netherlands--to help manage the triage and clinical surveillance of Covid-19 patients.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
May 26, 2020 10:32 ET (14:32 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Koninklijke Philips NV Chart |
1 Month Koninklijke Philips NV Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
